Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.

Translocator protein 18 kDa (TSPO) is an outer-mitochondrial membrane transporter which has many functions including participation in the mitochondrial permeability transition pore, regulation of reactive oxygen species (ROS), production of cellular energy, and is the rate-limiting step in the uptak...

Full description

Bibliographic Details
Main Authors: Misty M Thompson, H Charles Manning, Kate L J Ellacott
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3832377?pdf=render
id doaj-1d815749d6de40c4a7f304e1eafae6b5
record_format Article
spelling doaj-1d815749d6de40c4a7f304e1eafae6b52020-11-25T01:37:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e7998010.1371/journal.pone.0079980Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.Misty M ThompsonH Charles ManningKate L J EllacottTranslocator protein 18 kDa (TSPO) is an outer-mitochondrial membrane transporter which has many functions including participation in the mitochondrial permeability transition pore, regulation of reactive oxygen species (ROS), production of cellular energy, and is the rate-limiting step in the uptake of cholesterol. TSPO expression is dysregulated during disease pathologies involving changes in tissue energy demands such as cancer, and is up-regulated in activated macrophages during the inflammatory response. Obesity is associated with decreased energy expenditure, mitochondrial dysfunction, and chronic low-grade inflammation which collectively contribute to the development of the Metabolic Syndrome. Therefore, we hypothesized that dysregulation of TSPO in adipose tissue may be a feature of disease pathology in obesity. Radioligand binding studies revealed a significant reduction in TSPO ligand binding sites in mitochondrial extracts from both white (WAT) and brown adipose tissue (BAT) in mouse models of obesity (diet-induced and genetic) compared to control animals. We also confirmed a reduction in TSPO gene expression in whole tissue extracts from WAT and BAT. Immunohistochemistry in WAT confirmed TSPO expression in adipocytes but also revealed high-levels of TSPO expression in WAT macrophages in obese animals. No changes in TSPO expression were observed in WAT or BAT after a 17 hour fast or 4 hour cold exposure. Treatment of mice with the TSPO ligand PK11195 resulted in regulation of metabolic genes in WAT. Together, these results suggest a potential role for TSPO in mediating adipose tissue homeostasis.http://europepmc.org/articles/PMC3832377?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Misty M Thompson
H Charles Manning
Kate L J Ellacott
spellingShingle Misty M Thompson
H Charles Manning
Kate L J Ellacott
Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.
PLoS ONE
author_facet Misty M Thompson
H Charles Manning
Kate L J Ellacott
author_sort Misty M Thompson
title Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.
title_short Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.
title_full Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.
title_fullStr Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.
title_full_unstemmed Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity.
title_sort translocator protein 18 kda (tspo) is regulated in white and brown adipose tissue by obesity.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Translocator protein 18 kDa (TSPO) is an outer-mitochondrial membrane transporter which has many functions including participation in the mitochondrial permeability transition pore, regulation of reactive oxygen species (ROS), production of cellular energy, and is the rate-limiting step in the uptake of cholesterol. TSPO expression is dysregulated during disease pathologies involving changes in tissue energy demands such as cancer, and is up-regulated in activated macrophages during the inflammatory response. Obesity is associated with decreased energy expenditure, mitochondrial dysfunction, and chronic low-grade inflammation which collectively contribute to the development of the Metabolic Syndrome. Therefore, we hypothesized that dysregulation of TSPO in adipose tissue may be a feature of disease pathology in obesity. Radioligand binding studies revealed a significant reduction in TSPO ligand binding sites in mitochondrial extracts from both white (WAT) and brown adipose tissue (BAT) in mouse models of obesity (diet-induced and genetic) compared to control animals. We also confirmed a reduction in TSPO gene expression in whole tissue extracts from WAT and BAT. Immunohistochemistry in WAT confirmed TSPO expression in adipocytes but also revealed high-levels of TSPO expression in WAT macrophages in obese animals. No changes in TSPO expression were observed in WAT or BAT after a 17 hour fast or 4 hour cold exposure. Treatment of mice with the TSPO ligand PK11195 resulted in regulation of metabolic genes in WAT. Together, these results suggest a potential role for TSPO in mediating adipose tissue homeostasis.
url http://europepmc.org/articles/PMC3832377?pdf=render
work_keys_str_mv AT mistymthompson translocatorprotein18kdatspoisregulatedinwhiteandbrownadiposetissuebyobesity
AT hcharlesmanning translocatorprotein18kdatspoisregulatedinwhiteandbrownadiposetissuebyobesity
AT kateljellacott translocatorprotein18kdatspoisregulatedinwhiteandbrownadiposetissuebyobesity
_version_ 1725060312325947392